29 related articles for article (PubMed ID: 27566229)
1. Mechanisms of beneficial effects of metformin on fatty acid-treated human islets.
Cen J; Sargsyan E; Forslund A; Bergsten P
J Mol Endocrinol; 2018 Oct; 61(3):91-99. PubMed ID: 30307162
[TBL] [Abstract][Full Text] [Related]
2. Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.
Graaf Cd; Donnelly D; Wootten D; Lau J; Sexton PM; Miller LJ; Ahn JM; Liao J; Fletcher MM; Yang D; Brown AJ; Zhou C; Deng J; Wang MW
Pharmacol Rev; 2016 Oct; 68(4):954-1013. PubMed ID: 27630114
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular safety of therapies for type 2 diabetes.
Gupta P; White WB
Expert Opin Drug Saf; 2017 Jan; 16(1):13-25. PubMed ID: 27652617
[TBL] [Abstract][Full Text] [Related]
4. Addition of or switch to insulin therapy in people treated with glucagon-like peptide-1 receptor agonists: A real-world study in 66 583 patients.
Montvida O; Klein K; Kumar S; Khunti K; Paul SK
Diabetes Obes Metab; 2017 Jan; 19(1):108-117. PubMed ID: 27629433
[TBL] [Abstract][Full Text] [Related]
5. The acute anorexic effect of liraglutide, a GLP-1 receptor agonist, does not require functional leptin receptor, serotonin, and hypothalamic POMC and CART activities in mice.
Nonogaki K; Kaji T
Diabetes Res Clin Pract; 2016 Oct; 120():186-9. PubMed ID: 27585115
[TBL] [Abstract][Full Text] [Related]
6. The molecular basis for the prolonged blood circulation of lipidated incretin peptides: Peptide oligomerization or binding to serum albumin?
Wang Y; Lomakin A; Kanai S; Alex R; Belli S; Donzelli M; Benedek GB
J Control Release; 2016 Nov; 241():25-33. PubMed ID: 27578099
[TBL] [Abstract][Full Text] [Related]
7. Basal Insulin Use With GLP-1 Receptor Agonists.
Anderson SL; Trujillo JM
Diabetes Spectr; 2016 Aug; 29(3):152-60. PubMed ID: 27574369
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like peptide-1 attenuates advanced oxidation protein product-mediated damage in islet microvascular endothelial cells partly through the RAGE pathway.
Zhang Z; Yang L; Lei L; Chen R; Chen H; Zhang H
Int J Mol Med; 2016 Oct; 38(4):1161-9. PubMed ID: 27574116
[TBL] [Abstract][Full Text] [Related]
9. GPCR-mediated effects of fatty acids and bile acids on glucose homeostasis.
Oteng AB; Liu L
Front Endocrinol (Lausanne); 2023; 14():1206063. PubMed ID: 37484954
[TBL] [Abstract][Full Text] [Related]
10. Impaired HMG-CoA Reductase Activity Caused by Genetic Variants or Statin Exposure: Impact on Human Adipose Tissue, β-Cells and Metabolome.
Sarsenbayeva A; Jui BN; Fanni G; Barbosa P; Ahmed F; Kristófi R; Cen J; Chowdhury A; Skrtic S; Bergsten P; Fall T; Eriksson JW; Pereira MJ
Metabolites; 2021 Aug; 11(9):. PubMed ID: 34564389
[TBL] [Abstract][Full Text] [Related]
11. Recent Insights Into Mechanisms of β-Cell Lipo- and Glucolipotoxicity in Type 2 Diabetes.
Lytrivi M; Castell AL; Poitout V; Cnop M
J Mol Biol; 2020 Mar; 432(5):1514-1534. PubMed ID: 31628942
[TBL] [Abstract][Full Text] [Related]
12. Repression of sterol regulatory element-binding protein 1-c is involved in the protective effects of exendin-4 in pancreatic β-cell line.
Hong SW; Lee J; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Mol Cell Endocrinol; 2012 Oct; 362(1-2):242-52. PubMed ID: 22820130
[TBL] [Abstract][Full Text] [Related]
13. Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line.
Wei Q; Sun YQ; Zhang J
Peptides; 2012 Sep; 37(1):18-24. PubMed ID: 22776329
[TBL] [Abstract][Full Text] [Related]
14. Diabetes outfoxed by GLP-1?
Holz GG; Chepurny OG
Sci STKE; 2005 Jan; 2005(268):pe2. PubMed ID: 15671479
[TBL] [Abstract][Full Text] [Related]
15. Treatment of type 2 diabetes mellitus with agonists of the GLP-1 receptor or DPP-IV inhibitors.
Holst JJ
Expert Opin Emerg Drugs; 2004 May; 9(1):155-66. PubMed ID: 15155141
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 analogue recovers impaired insulin secretion from human islets treated with palmitate via down-regulation of SOCS2.
Chowdhury AI; Bergsten P
Mol Cell Endocrinol; 2017 Jan; 439():194-202. PubMed ID: 27566229
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Exposure of Pancreatic β-Cells to Palmitate Results in SREBP-1C-Dependent Decreases in GLP-1 Receptor Signaling via CREB and AKT and Insulin Secretory Response.
Natalicchio A; Biondi G; Marrano N; Labarbuta R; Tortosa F; Spagnuolo R; D'Oria R; Carchia E; Leonardini A; Cignarelli A; Perrini S; Laviola L; Giorgino F
Endocrinology; 2016 Jun; 157(6):2243-58. PubMed ID: 27035653
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
